Cue Biopharma, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-23.2M |
| Depreciation & Amortization | — |
| Depreciation | $419.6K |
| Amortization | — |
| Stock-Based Compensation | $2.8M |
| Net Cash from Operating Activities | $-12.1M |
| Investing Activities | |
| Capital Expenditures | $1.0M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-1.2M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $62.0M |
| Net Change in Cash | $48.7M |
| Free Cash Flow | $-13.2M |